Lazard Asset Management LLC Bridge Bio Pharma, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 38 shares of BBIO stock, worth $1,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 3,905
99.03%
Holding current value
$1,428
Previous $98,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$950 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$944 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$534 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$468 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$228 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.57B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...